LivaNova (LIVN) Other Accumulated Expenses (2025 - 2026)
LivaNova (LIVN) posted Other Accumulated Expenses of $389.5 million for Q1 2026, down 1.71% sequentially from $396.2 million in Q4 2025, and up 8.07% YoY from $360.4 million in Q1 2025.
LivaNova (LIVN) Other Accumulated Expenses (2025 - 2026) Analysis & Trends
LivaNova has reported Other Accumulated Expenses for 2 years, with the latest figure at $389.5 million in Q1 2026.
- Quarterly Other Accumulated Expenses rose 8.07% year-over-year to $389.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $389.5 million (up 8.07% YoY) and the FY2025 annual result came in at $396.2 million, changed N/A from the prior year.
- Other Accumulated Expenses eased to $389.5 million in Q1 2026 per LIVN's latest filing, from $396.2 million in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $396.2 million in Q4 2025 and troughed at $360.4 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.91 Bn | 193.31 Bn | 7.27 Bn |
| 2 | Stryker | 127.59 Bn | 124.11 Bn | 4.50 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.24 Bn | 72.70 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn |
| 6 | Dexcom | 34.38 Bn | 32.44 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.96 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.08 Bn | 22.60 Bn | 684.20 Mn |
| 10 | LivaNova | 4.29 Bn | 3.77 Bn | 273.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 385.02 Mn |
| Mar 31, 2026 | 389.49 Mn |
| Dec 31, 2025 | 396.24 Mn |
| Sep 30, 2025 | 394.59 Mn |
| Jun 30, 2025 | 392.27 Mn |
| Mar 31, 2025 | 360.39 Mn |